Skip to main content
Top
Published in: International Journal of Hematology 5/2019

01-11-2019 | Anemia | Original Article

Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach

Authors: Prabhakar S. Kedar, Hideo Harigae, Etsuro Ito, Hideki Muramatsu, Seiji Kojima, Yusuke Okuno, Tohru Fujiwara, Rashmi Dongerdiye, Prashant P. Warang, Manisha R. Madkaikar

Published in: International Journal of Hematology | Issue 5/2019

Login to get access

Abstract

Most patients with anemia are diagnosed through clinical phenotype and basic laboratory testing. Nonetheless, in cases of rare congenital anemias, some patients remain undiagnosed despite undergoing an exhaustive workup. Genetic testing is complicated by the large number of genes that are involved in rare anemias, due to similarities in the clinical presentation. We sought to enhance the diagnosis of patients with congenital anemias by using targeted next-generation sequencing. The genetic diagnosis was performed by gene capture followed by next-generation sequencing of 76 genes known to cause anemia syndromes. Genetic diagnosis was achieved in 17 of 21 transfusion-dependent patients and undiagnosed by conventional workup. Four cases were diagnosed with red cell membrane protein defects, four patients were diagnosed with pyruvate kinase deficiency, one case of adenylate kinase deficiency, one case of glucose phosphate isomerase deficiency, one case of hereditary xerocytosis, three cases having combined membrane and enzyme defect, two cases with Diamond–Blackfan anemia (DBA) and 1 with CDA type II with 26 different mutations, of which 21 are novel. Earlier incorporation of this NGS method into the workup of patients with congenital anemia may improve patient care and enable genetic counselling.
Literature
1.
go back to reference Jacobasch G, Rapoport SM. Hemolytic anemias due to erythrocyte enzyme deficiencies. Mol Aspects Med. 1996;17(2):143–70.CrossRefPubMed Jacobasch G, Rapoport SM. Hemolytic anemias due to erythrocyte enzyme deficiencies. Mol Aspects Med. 1996;17(2):143–70.CrossRefPubMed
2.
go back to reference Clarke GM, Higins T. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin Chem. 2000;46(8):1284–90.PubMed Clarke GM, Higins T. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin Chem. 2000;46(8):1284–90.PubMed
3.
go back to reference Chiu D, Lubin B. Oxidative hemoglobin denaturation and RBC destruction: the effect of heme on red cell membranes. Semin Hematol. 1989;26(2):128–35.PubMed Chiu D, Lubin B. Oxidative hemoglobin denaturation and RBC destruction: the effect of heme on red cell membranes. Semin Hematol. 1989;26(2):128–35.PubMed
4.
go back to reference King MJ, Zanella A. Hereditary red cell membrane disorders and laboratory diagnostic testing. Int J Lab Hematol. 2013;35(3):237–43.CrossRefPubMed King MJ, Zanella A. Hereditary red cell membrane disorders and laboratory diagnostic testing. Int J Lab Hematol. 2013;35(3):237–43.CrossRefPubMed
5.
go back to reference Koralkova P, Van Solinge WW, Van Wijk R. Rare hereditary red blood cell enzymopathies associated with hemolytic anemia- pathophysiology, clinical aspects, and laboratory diagnosis. Int J Lab Hematol. 2014;36(3):388–97.CrossRefPubMed Koralkova P, Van Solinge WW, Van Wijk R. Rare hereditary red blood cell enzymopathies associated with hemolytic anemia- pathophysiology, clinical aspects, and laboratory diagnosis. Int J Lab Hematol. 2014;36(3):388–97.CrossRefPubMed
6.
go back to reference Gallagher PG. Diagnosis and management of the rare congenital nonimmune hemolytic disease. Hematol Am Soc Hematol Educ Program. 2015;1:392–9.CrossRef Gallagher PG. Diagnosis and management of the rare congenital nonimmune hemolytic disease. Hematol Am Soc Hematol Educ Program. 2015;1:392–9.CrossRef
7.
go back to reference Barcellini W, Fattizzo B. Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers. 2015;2015:635–70.CrossRef Barcellini W, Fattizzo B. Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers. 2015;2015:635–70.CrossRef
8.
go back to reference Kedar PS, Parmar V, Devendra R, Gupta V, Warang P, Madkaikar M. Congenital dyserythropoietic anemia type-II mimicking hereditary spherocytosis in an indian patient with SEC23B-Y462C mutations. Ann Hematol. 2017;96(12):2135–9.CrossRefPubMed Kedar PS, Parmar V, Devendra R, Gupta V, Warang P, Madkaikar M. Congenital dyserythropoietic anemia type-II mimicking hereditary spherocytosis in an indian patient with SEC23B-Y462C mutations. Ann Hematol. 2017;96(12):2135–9.CrossRefPubMed
9.
go back to reference Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB, García-Orad A, Tejada MI, Garcia-Ruiz JC, et al. Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing. Int J Lab Hematol. 2016;38(6):629–38.CrossRef Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB, García-Orad A, Tejada MI, Garcia-Ruiz JC, et al. Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing. Int J Lab Hematol. 2016;38(6):629–38.CrossRef
10.
go back to reference Lin PC, Chiou SS, Lin CY, Wang SC, Huang HY, Chang YS, et al. Whole-exome sequencing for the genetic diagnosis of congenital red blood cell membrane disorders in Taiwan. Clin Chim Acta. 2018;487:311–7.CrossRefPubMed Lin PC, Chiou SS, Lin CY, Wang SC, Huang HY, Chang YS, et al. Whole-exome sequencing for the genetic diagnosis of congenital red blood cell membrane disorders in Taiwan. Clin Chim Acta. 2018;487:311–7.CrossRefPubMed
11.
go back to reference Dacie JV, Lewis SM. Practical hematology. 8th ed. London: Churchill Livingston; 1999. Dacie JV, Lewis SM. Practical hematology. 8th ed. London: Churchill Livingston; 1999.
12.
go back to reference Warang P, Gupta M, Kedar P, Ghosh K, Colah R. Flow cytometric osmotic fragility-an effective screening approach for red cell membranopathies. Cytometry B Clin Cytom. 2011;80(3):186–90.CrossRefPubMed Warang P, Gupta M, Kedar P, Ghosh K, Colah R. Flow cytometric osmotic fragility-an effective screening approach for red cell membranopathies. Cytometry B Clin Cytom. 2011;80(3):186–90.CrossRefPubMed
13.
go back to reference Kedar PS, Colah RB, Kulkarni S, Ghosh K, Mohanty D. Experience with eosin-5′-maleimide as a diagnostic tool for red cell membrane disorders. Clin Lab Haematol. 2003;25(6):373–6.CrossRefPubMed Kedar PS, Colah RB, Kulkarni S, Ghosh K, Mohanty D. Experience with eosin-5′-maleimide as a diagnostic tool for red cell membrane disorders. Clin Lab Haematol. 2003;25(6):373–6.CrossRefPubMed
14.
go back to reference King MJ, Garçon L, Hoyer JD, Iolascon A, Picard V, Stewart G, et al. International Council for Standardization in Haematology ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 2015;37(3):304–25.CrossRefPubMed King MJ, Garçon L, Hoyer JD, Iolascon A, Picard V, Stewart G, et al. International Council for Standardization in Haematology ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 2015;37(3):304–25.CrossRefPubMed
15.
go back to reference Beutler E. Red cell metabolism: a manual of biochemical methods. 3rd ed. Orlando: Grune & Stratton; 1984. Beutler E. Red cell metabolism: a manual of biochemical methods. 3rd ed. Orlando: Grune & Stratton; 1984.
16.
go back to reference Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, A laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, A laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
17.
go back to reference Warang P, Kedar P, Ghosh K, Colah R. Molecular and clinical heterogeneity in pyruvate kinase deficiency in India. Blood Cells Mol Dis. 2013;51(3):133–7.CrossRefPubMed Warang P, Kedar P, Ghosh K, Colah R. Molecular and clinical heterogeneity in pyruvate kinase deficiency in India. Blood Cells Mol Dis. 2013;51(3):133–7.CrossRefPubMed
18.
go back to reference Kedar P, Hamada T, Warang P, Nadkarni A, Shimizu K, Fujji H, et al. Spectrum of novel mutations in the human PKLR gene in pyruvate kinase-deficient Indian patients with heterogeneous clinical phenotypes. Clin Genet. 2009;75(2):157–62.CrossRefPubMed Kedar P, Hamada T, Warang P, Nadkarni A, Shimizu K, Fujji H, et al. Spectrum of novel mutations in the human PKLR gene in pyruvate kinase-deficient Indian patients with heterogeneous clinical phenotypes. Clin Genet. 2009;75(2):157–62.CrossRefPubMed
19.
go back to reference Kedar PS, Dongerdiye R, Chilwirwar P, Gupta V, Chiddarwar A, Devendra R, et al. Glucose phosphate isomerase deficiency: high prevalence of p.Arg347His mutation in indian population associated with severe hereditary non-spherocytic hemolytic anemia coupled with neurological dysfunction. Indian J Pediatr. 2019;1:1. https://doi.org/10.1007/s12098-019-02928-1.CrossRef Kedar PS, Dongerdiye R, Chilwirwar P, Gupta V, Chiddarwar A, Devendra R, et al. Glucose phosphate isomerase deficiency: high prevalence of p.Arg347His mutation in indian population associated with severe hereditary non-spherocytic hemolytic anemia coupled with neurological dysfunction. Indian J Pediatr. 2019;1:1. https://​doi.​org/​10.​1007/​s12098-019-02928-1.CrossRef
20.
go back to reference He F, Zhou W, Cai R, Yan T, Xu X. Systematic assessment of the performance of whole-genome amplification for SNP/CNV detection and β-thalassemia genotyping. J Hum Genet. 2018;63(4):407–16.CrossRefPubMed He F, Zhou W, Cai R, Yan T, Xu X. Systematic assessment of the performance of whole-genome amplification for SNP/CNV detection and β-thalassemia genotyping. J Hum Genet. 2018;63(4):407–16.CrossRefPubMed
21.
go back to reference Shefer Averbuch N, Steinberg-Shemer O, Dgany O, Krasnov T, Noy-Lotan S, Yacobovich J, et al. Targeted next-generation sequencing for the diagnosis of patients with rare congenital anemias. Eur J Haematol. 2018;101(3):297–304.CrossRefPubMed Shefer Averbuch N, Steinberg-Shemer O, Dgany O, Krasnov T, Noy-Lotan S, Yacobovich J, et al. Targeted next-generation sequencing for the diagnosis of patients with rare congenital anemias. Eur J Haematol. 2018;101(3):297–304.CrossRefPubMed
22.
go back to reference Dongerdiye R, Kamat P, Jain P, Warang P, Devendra R, Wasekar N, et al. Red cell adenylate kinase deficiency in India: identification of two novel missense mutations (c.71A>G and c.413G>A). J Clin Pathol. 2019;72(6):393–8.CrossRefPubMed Dongerdiye R, Kamat P, Jain P, Warang P, Devendra R, Wasekar N, et al. Red cell adenylate kinase deficiency in India: identification of two novel missense mutations (c.71A>G and c.413G>A). J Clin Pathol. 2019;72(6):393–8.CrossRefPubMed
23.
go back to reference Kedar PS, Dongerdiye R, Chilwirwar P, Gupta V, Chiddarwar A, Devendra R, et al. Molecular diagnosis of unexplained haemolytic anaemia using targeted next-generation sequencing panel revealed (p.Ala337Thr) novel mutation in GPI gene in two Indian patients. J Clin Pathol. 2019;72(1):81–5.CrossRefPubMed Kedar PS, Dongerdiye R, Chilwirwar P, Gupta V, Chiddarwar A, Devendra R, et al. Molecular diagnosis of unexplained haemolytic anaemia using targeted next-generation sequencing panel revealed (p.Ala337Thr) novel mutation in GPI gene in two Indian patients. J Clin Pathol. 2019;72(1):81–5.CrossRefPubMed
24.
go back to reference Shooter C, Rooks H, Lay S, Clark B. Next-generation sequencing identifies a novel rearrangement in the HBB cluster permitting to-the-base characterization. Hum Mutat. 2015;36(1):142–50.CrossRefPubMed Shooter C, Rooks H, Lay S, Clark B. Next-generation sequencing identifies a novel rearrangement in the HBB cluster permitting to-the-base characterization. Hum Mutat. 2015;36(1):142–50.CrossRefPubMed
25.
go back to reference Shen W, Paxton CN, Szankasi P, Longhurst M, Schumacher JA, Frizzell KA, et al. Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing. J Clin Pathol. 2018;71(4):372–8.CrossRefPubMed Shen W, Paxton CN, Szankasi P, Longhurst M, Schumacher JA, Frizzell KA, et al. Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing. J Clin Pathol. 2018;71(4):372–8.CrossRefPubMed
26.
go back to reference Russo R, Andolfo I, Manna F, Gambale A, Marra R, Rosato BE, et al. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias. Am J Hematol. 2018;93(5):672–82.CrossRefPubMed Russo R, Andolfo I, Manna F, Gambale A, Marra R, Rosato BE, et al. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias. Am J Hematol. 2018;93(5):672–82.CrossRefPubMed
27.
go back to reference Roy NB, Wilson EA, Henderson S, Wray K, Babbs C, Okoli S, et al. A novel 33-Gene-targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias. Br J Haematol. 2016;175(3):318–30.CrossRefPubMedPubMedCentral Roy NB, Wilson EA, Henderson S, Wray K, Babbs C, Okoli S, et al. A novel 33-Gene-targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias. Br J Haematol. 2016;175(3):318–30.CrossRefPubMedPubMedCentral
Metadata
Title
Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach
Authors
Prabhakar S. Kedar
Hideo Harigae
Etsuro Ito
Hideki Muramatsu
Seiji Kojima
Yusuke Okuno
Tohru Fujiwara
Rashmi Dongerdiye
Prashant P. Warang
Manisha R. Madkaikar
Publication date
01-11-2019
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2019
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-019-02716-9

Other articles of this Issue 5/2019

International Journal of Hematology 5/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine